ArticleNature communications2018

Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles.

Fred C Lam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.